SOFWAVE

Sofwave Medical Ltd. is a global medical device company founded in 2015 by Dr. Shimon Eckhouse and Ariel Sverdlik. It is headquartered in Orange County, United States, with operations around the world. The corporate, R&D and manufacturing headquarters of Sofwave are located in Israel.
Sofwave is best known for its proprietary Synchronous Ultrasound Parallel Beam SUPERB™ technology that is used for non-invasive aesthetic treatments. Since its foundation, Sofwave’s technology is FDA cleared and clinically proven to improve facial lines, reduce wrinkles and contribute to collagen remodelling.
Sofwave, for its groundbreaking technology, continues to make notable advancements in the medical field. The company has been featured in several media outlets including PR News Wire, Haute Living, Space Coast Daily, Globes English, BioSpace, and others.
==History==
Sofwave was founded in 2015 with the aim to revolutionize the aesthetic medical industry by Dr. Shimon Eckhouse and Ariel Sverdlik. Sverdlik is a medical researcher and developer with over two decades of experience in offering high-intensity ultrasound technology for a wide range of medical and aesthetic applications, whereas Dr. Eckhouse is a leading entrepreneur and investor known for his involvement in the medical technology industry, with investments in over 20 companies.
Sofwave follows a minimally invasive procedure that is unique for every patient by incorporating the proprietary Synchronous Ultrasound Parallel Beam SUPERB™ technology. The idea behind creating such technology was to allow the physicians to have an easier and non-invasive approach to perform aesthetic procedures especially the treatments that address an ongoing need for practices to those who seek a highly effective non-invasive technology solution for wrinkle reduction.
==Products==
Sofwave offers a proprietary FDA-approved Synchronous Ultrasound Parallel Beam SUPERB™ technology that is non invasive, reasonable, and applicable for all s kin types. This treatment is specifically made for skin collagen remodeling and wrinkle reduction.
This treatment offered by Sofwave lasts for 30-45 Minutes for a full face treatment with no reported post-procedure pain or special post-procedure care requirement. It is also integrated with SofCool™ that protects the outer skin layer and enables treatment ensuring no damage to the underlying structures beneath the dermis.
The highlighting feature of Sofwave’s offering is that it incorporates an advanced technology that is offered to the practitioners at a comparatively low consumable cost. Sofwave ultrasound technology is the world’s first one of a kind technology that coagulates tissue area at the depth of 1.5 mm in the mid-dermis to reduce fine lines and wrinkles in half the treatment time as compared to other methods.
==Funding==
Sofwave Medical has raised $8.4 Million in a funding round in 2019 where Shimon Eckhouse and XT Hi-Tech were the lead investors.
==In the media==
<youtube width="300" height="300">Y_2ivJ2l5w8</youtube>  
<youtube width="300" height="300">tAU6HIrDOzk</youtube>  
<youtube width="300" height="300">lNTiql97XO0</youtube>  
<youtube width="300" height="300">N3SzRcJmSlc</youtube>
==References==
==External links==
* Official Website
* 
* 
* 
* 
* 
Category:Companies established in 2015
Category:Companies based in Orange County, California
Category:Medical device manufacturers
Category:Medical technology companies